Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10510990 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluation of Cilostazol in Combination With L-Carnitine
Conditions: Peripheral Vascular Disease;   Intermittent Claudication;   Peripheral Arterial Disease
Interventions: Dietary Supplement: Levocarnitine tartrate;   Drug: cilostazol

Indicates status has not been verified in more than two years